“…However, both assertions will be subject to the patient clinical history, ECG findings, monitoring, and disease control ( Thygesen et al , 2018 ). Due to its cardiospecificity, cTnI has demonstrated its functionality in the differential diagnosis, where there are different phases of myocardial ischemia associated with other cardiac conditions such as myocarditis, heart failure, ischemic heart disease, and stable angina, especially in relapsed patients ( Korff et al, 2006 ; Januzzi et al, 2019 ; Tandon et al, 2019 ; Chaulin, 2021a ; Chaulin, 2021b ).…”